Amphastar Pharmaceuticals, Inc.

AMPH Healthcare Drug Manufacturers Specialty & Generic

Amphastar Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $719.9 million, down 1.65% from fiscal 2024. In the quarter to June 2026, revenue grew 5.44%, EPS grew 4.55%, free cash flow grew 87.6% and total debt was flat, each against the same quarter a year earlier.

25.87 0.55 −2.08%
Market cap
$1.1B
P/E
14.9×
Fwd P/E
14.7×
Dividend yield
—
F-score
6/9
Altman Z
2.54
Beneish M
−2.57
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
636.02 534.07 489.60 378.32 318.12 279.68 255.24 220.34 187.78 184.10
Total non-current assets
993.28 1,043.40 1,023.31 363.67 353.41 351.55 331.73 293.22 263.29 243.64
Total Assets
1,629.30 1,577.47 1,512.91 741.99 671.53 631.24 586.97 513.56 451.07 427.74
Total current liabilities
158.16 173.76 225.41 94.86 103.81 112.20 90.01 106.83 67.19 60.62
Total non-current liabilities
682.34 671.41 648.08 118.47 122.20 70.31 69.43 42.37 50.14 37.87
Total liabilities
840.49 845.17 873.49 213.33 226.01 182.51 159.44 149.20 117.34 98.48
Common Equity (Total)
788.80 732.30 639.42 528.66 445.52 448.72 427.53 364.36 333.74 329.26
Shareholders Equity (Total)
788.81 732.30 639.42 528.66 445.52 448.72 427.53 364.36 333.74 329.26
Total Debt
610.39 601.86 590.02 75.89 76.98 46.45 47.14 50.21 47.16 37.72

Show all line items

In millions of $ except per-share values · columns are period end dates